KU Leuven is a non-profit university headquartered in Belgium. Founded in 1425, it employs approximately 13,910 people. The university operates as a multidisciplinary institution based in Leuven.
KU Leuven researchers are mapping how to conduct experimental research on anxiety-related symptoms more reliably and clinically relevantly, focusing on 'symptom provocation' methods to trigger anxiety responses and study underlying mechanisms, as reported on March 31, 2026. Previously, experimental research by the KU Leuven Rega Institute indicated on March 26 that vaccine efficacy might not solely depend on neutralising antibodies, but can also be achieved through specific white blood cells. Earlier, on March 23, researchers developed a technique allowing genetically modified bacteria to grow in a controlled and temporary way instead of exponentially, with this proof-of-concept study published in Nature Communications opening possibilities for safe bacterial use in medicine or agriculture. On March 18, the university reported that liver alkaline phosphatase (ALP) levels, which increase progressively across chronic kidney disease (CKD) stages driven by liver, bone, and intestinal fractions, were linked to inflammation and independently predicted the risk for five-year mortality in patients undergoing haemodialysis. This followed research published on February 3, showing that targeted adjustments to buildings and urban spaces, particularly 'cool roofs' that reflect sunlight instead of absorbing it, can significantly limit the impact of heatwaves in cities.
Subscribe for full access to KU Leuven's products in full detail
Subscribe for full access to KU Leuven's revenue in full detail
Subscribe for full access to KU Leuven's products in full detail 
